Naringin nano inhalation powder inhalation taking polylysine as carrier as well as preparation method and application of naringin nano inhalation powder inhalation

A technology for inhaling powder mist and naringin nanotechnology, which is applied in nanotechnology, nanomedicine, nanotechnology, etc., can solve the problems of long inhalation duration, dependence on drug delivery devices, and difficulty in popularization, so as to reduce drug side effects, The effect of improving the curative effect of the drug and the preparation process is simple

Active Publication Date: 2022-03-18
INST OF MEDICINAL PLANT DEV CHINESE ACADEMY OF MEDICAL SCI
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Due to the inconsistency between start-up and inhalation of aerosol, the rapid evaporation of the propellant during start-up produces a cooling effect, and the impact of propellant Freon on environmental protection, etc., its application is subject to certain restrictions, especially for active protein and polypeptide

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Naringin nano inhalation powder inhalation taking polylysine as carrier as well as preparation method and application of naringin nano inhalation powder inhalation
  • Naringin nano inhalation powder inhalation taking polylysine as carrier as well as preparation method and application of naringin nano inhalation powder inhalation
  • Naringin nano inhalation powder inhalation taking polylysine as carrier as well as preparation method and application of naringin nano inhalation powder inhalation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0045]Next, the technical solutions in the embodiments of the present invention will be described in conjunction with the drawings of the present invention. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art are in the range of the present invention without making creative labor premise.

[0046] The example of the present invention discloses a method of preparing a pomardroside nano-induced pocalin nano-induced binder in a vector, not only the preparation process is simple, but also the preparation of teak nano-suspended agent is high, and the accumulated release in vivo Good effect, can improve the efficacy of drugs, suitable for market promotion and application.

[0047] In order to better understand the present invention, the present invention will be further illustrated by the following examples, but it is not understood to be limited to the present invention, and some non-essential improvements and adjustme...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the field of nano-drug inhalation preparations, in particular to preparation of naringin nano-inhalation powder inhalation taking polylysine PL as a carrier and research on the treatment effect of the naringin nano-inhalation powder inhalation on cough after infection. The preparation method comprises the following steps: firstly, preparing a naringin nano suspension by adopting a medium grinding method based on a Top-down principle, and then further drying and curing by adopting a spray drying method to obtain the naringin nano inhalation powder aerosol. The naringin nano inhalation powder inhalation disclosed by the invention is simple in preparation process, high in drug loading capacity and good in in-vivo release effect; in-vivo pharmacodynamic experiment results show that the prepared naringin nano inhalation dry powder can significantly improve the cough relieving, anti-inflammatory and anti-oxidation curative effects of the medicine, and the naringin nano inhalation dry powder enables the medicine and a carrier to be absolutely safe due to the fact that no organic reagent is added in the whole preparation process, and has great market application and popularization prospects.

Description

Technical field [0001] The present invention relates to the field of nano-drug suction preparations, and more particularly to the preparation of pombletyin nano inhalation of pompelopolis nano induced by polylysine P1 and its study on cough in infection. Background technique [0002] Studies have shown that pomodinis has bioactivity such as cough, anti-inflammatory, anti-oxidation, but pomeline is low due to low solubility, slow dissolution, resulting in poor oral bioavailability, and the pharmacodynamic effect is not fully played in the body, thus limiting its clinic application. At present, the method of improving the solubility of the difficult soluble drug has a salt, a co-solvent, micronized, and has a solid dispersion and prodrug, but each method has certain limitations. [0003] PL is rich in cation, can be prepared into a nano system by static power, and has good penetration for the biofilm. Based on this feature of polylysine can be used for some drug carriers, therefore...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/72A61K31/7048A61K47/34A61P11/00A61P31/04A61P29/00A61P11/06A61P11/14B82Y5/00B82Y40/00
CPCA61K9/0075A61K9/146A61K31/7048A61P11/00A61P31/04A61P29/00A61P11/06A61P11/14B82Y5/00B82Y40/00Y02A50/30
Inventor 郭一飞董政起王晓桐韩美华王向涛
Owner INST OF MEDICINAL PLANT DEV CHINESE ACADEMY OF MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products